KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash & Current Investments (2016 - 2026)

Globus Medical filings provide 15 years of Cash & Current Investments readings, the most recent being $557.2 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 37.39% to $557.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $557.2 million, a 37.39% decrease, with the full-year FY2025 number at $557.2 million, down 37.39% from a year prior.
  • Cash & Current Investments hit $557.2 million in Q4 2025 for Globus Medical, up from $390.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $890.1 million in Q4 2024 to a low of $229.4 million in Q2 2025.
  • Median Cash & Current Investments over the past 5 years was $465.1 million (2023), compared with a mean of $492.4 million.
  • Biggest five-year swings in Cash & Current Investments: soared 71.9% in 2024 and later plummeted 53.45% in 2025.
  • Globus Medical's Cash & Current Investments stood at $443.4 million in 2021, then grew by 0.59% to $446.1 million in 2022, then increased by 16.08% to $517.8 million in 2023, then soared by 71.9% to $890.1 million in 2024, then crashed by 37.39% to $557.2 million in 2025.
  • The last three reported values for Cash & Current Investments were $557.2 million (Q4 2025), $390.5 million (Q3 2025), and $229.4 million (Q2 2025) per Business Quant data.